These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1140 related articles for article (PubMed ID: 30133276)
1. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands. Yang Y; Guo L; Ge X; Shi S; Gong Y; Xu Z; Zheng X; Liu Z J Inorg Biochem; 2019 Feb; 191():1-7. PubMed ID: 30445339 [TBL] [Abstract][Full Text] [Related]
3. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
4. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study. Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417 [TBL] [Abstract][Full Text] [Related]
5. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex. Zhang J; Liu J; Liu X; Liu B; Song S; He X; Che C; Si M; Yang G; Liu Z J Inorg Biochem; 2020 Jun; 207():111063. PubMed ID: 32222581 [TBL] [Abstract][Full Text] [Related]
6. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity. Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698 [TBL] [Abstract][Full Text] [Related]
7. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents. Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192 [TBL] [Abstract][Full Text] [Related]
8. Half-sandwich Iridium Han Y; Tian Z; Zhang S; Liu X; Li J; Li Y; Liu Y; Gao M; Liu Z J Inorg Biochem; 2018 Dec; 189():163-171. PubMed ID: 30268969 [TBL] [Abstract][Full Text] [Related]
9. Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies. Kong D; Tian M; Guo L; Liu X; Zhang S; Song Y; Meng X; Wu S; Zhang L; Liu Z J Biol Inorg Chem; 2018 Jul; 23(5):819-832. PubMed ID: 29934699 [TBL] [Abstract][Full Text] [Related]
10. Half-sandwich Iridium(III) Benzimidazole-Appended Imidazolium-Based N-heterocyclic Carbene Complexes and Antitumor Application. Han Y; Liu X; Tian Z; Ge X; Li J; Gao M; Li Y; Liu Y; Liu Z Chem Asian J; 2018 Dec; 13(23):3697-3705. PubMed ID: 30276978 [TBL] [Abstract][Full Text] [Related]
11. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes. Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678 [TBL] [Abstract][Full Text] [Related]
12. Phenoxide chelated Ir(iii) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity. Zhang Y; Zhang S; Tian Z; Li J; Xu Z; Li S; Liu Z Dalton Trans; 2018 Oct; 47(39):13781-13787. PubMed ID: 30238113 [TBL] [Abstract][Full Text] [Related]
13. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents. Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046 [TBL] [Abstract][Full Text] [Related]
14. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies. Li J; Guo L; Tian Z; Zhang S; Xu Z; Han Y; Li R; Li Y; Liu Z Inorg Chem; 2018 Nov; 57(21):13552-13563. PubMed ID: 30289251 [TBL] [Abstract][Full Text] [Related]
15. Half-sandwich iridium N-heterocyclic carbene anticancer complexes. Wang C; Liu J; Tian Z; Tian M; Tian L; Zhao W; Liu Z Dalton Trans; 2017 May; 46(21):6870-6883. PubMed ID: 28405646 [TBL] [Abstract][Full Text] [Related]
16. Imidazole and Benzimidazole Modified Half-Sandwich Iridium Liu X; Han Y; Ge X; Liu Z Front Chem; 2020; 8():182. PubMed ID: 32257999 [TBL] [Abstract][Full Text] [Related]
17. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes. Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807 [TBL] [Abstract][Full Text] [Related]
18. DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents. Ritacco I; Russo N; Sicilia E Inorg Chem; 2015 Nov; 54(22):10801-10. PubMed ID: 26492153 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of fluorine and Naphthyridine-Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity. Li J; Tian Z; Ge X; Xu Z; Feng Y; Liu Z Eur J Med Chem; 2019 Feb; 163():830-839. PubMed ID: 30579123 [TBL] [Abstract][Full Text] [Related]
20. Half-sandwich iridium(III) complexes with α-picolinic acid frameworks and antitumor applications. Hao H; Liu X; Ge X; Zhao Y; Tian X; Ren T; Wang Y; Zhao C; Liu Z J Inorg Biochem; 2019 Mar; 192():52-61. PubMed ID: 30597449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]